New imaging tool aims to cut repeat surgeries in breast cancer

NCT ID NCT05113927

Completed Disease control Sponsor: Perimeter Medical Imaging Source: ClinicalTrials.gov ↗

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This trial tests a device called SELENE that gives surgeons a detailed view of the tissue removed during breast-conserving surgery. The goal is to see if using this imaging helps surgeons remove all cancer cells the first time, reducing the chance that a patient needs another operation. The study involves women with early-stage breast cancer who are having lumpectomy surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: SELENE imaging device
What this could lead to: If successful, this device could help surgeons remove all cancer in one operation, reducing the need for additional surgeries and improving outcomes for breast cancer patients.
What could go wrong: The device is still being tested, and it may not significantly reduce positive margin rates. It also adds time to the surgery and may not work for all types of breast cancer.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm ductal breast carcinoma in situ invasive ductal breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Show contact details

Locations

Baptist MD Anderson Cancer Center

Jacksonville, Florida, 32207, United States
Baylor College of Medicine

Houston, Texas, 77030, United States
Holy Redeemer

Meadowbrook, Pennsylvania, 19046, United States
Mayo Clinic

Jacksonville, Florida, 32224, United States
Medical City Dallas

Dallas, Texas, 75230, United States
Methodist Healthcare of San Antonio

San Antonio, Texas, 78229, United States
Moffitt Cancer Center & Research Institute

Tampa, Florida, 33612, United States
University of Washington

Seattle, Washington, 98195, United States
University of Wisconsin

Madison, Wisconsin, 53792, United States
West Cancer Center & Research Institute

Germantown, Tennessee, 38138, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.